![Robert Arch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Arch
President på
Immunophotonics, Inc.
Profil
Robert H.
Arch currently works at Immunophotonics, Inc., as President from 2025.
Dr. Arch also formerly worked at OncoSec Medical, Inc., as President, CEO & Non-Independent Director from 2022 to 2023, Elpiscience Biopharma Ltd., as Head-Research from 2019 to 2021, and China Novartis Institutes for BioMedical Research Co., Ltd., as Head-Liver Disease Department from 2017 to 2019.
Dr. Arch received his doctorate degree from Julius-Maximilians-Universität Würzburg.
Aktiva positioner av Robert Arch
| Företag | Position | Start |
|---|---|---|
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | President | 2025-09-22 |
Tidigare kända positioner av Robert Arch
| Företag | Position | Slut |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Verkställande Direktör | 2023-06-14 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Teknisk/Vetenskaplig/F&U Direktör | 2021-06-01 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Företagsledare/Principal | 2019-10-01 |
Robert Archs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
23
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Health Technology |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |
